NASDAQ:ALKS
Alkermes plc Stock News
$24.68
+0.240 (+0.98%)
At Close: Apr 26, 2024
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) * Masimo Corporation (NASDAQ: MASI)Down In The Dum
Global Major Depressive Disorder (MDD) Market Insights, 2017-2028
10:08am, Friday, 13'th Mar 2020
Dublin, March 13, 2020 -- The "Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to.
Alkermes (NASDAQ:ALKS) Cut to "Sell" at BidaskClub
07:06am, Friday, 13'th Mar 2020
Alkermes (NASDAQ:ALKS) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday, BidAskClub reports. Other analysts a
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
KBC Group NV Reduces Stake in Alkermes Plc (NASDAQ:ALKS)
10:31am, Thursday, 12'th Mar 2020
KBC Group NV lowered its position in Alkermes Plc (NASDAQ:ALKS) by 64.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 5,963 shares of the company’s stock
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
$224.97 Million in Sales Expected for Alkermes Plc (NASDAQ:ALKS) This Quarter
08:10am, Wednesday, 11'th Mar 2020
Wall Street brokerages expect that Alkermes Plc (NASDAQ:ALKS) will report $224.97 million in sales for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates f
Bank of Montreal Can Has $4.71 Million Position in Alkermes Plc (NASDAQ:ALKS)
10:24am, Saturday, 07'th Mar 2020
Bank of Montreal Can boosted its holdings in shares of Alkermes Plc (NASDAQ:ALKS) by 2,262.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 231,026 shares of the c
U.S. credit markets endure worst decade in 10 years
07:12pm, Friday, 06'th Mar 2020
U.S. credit markets suffer their worst day in a decade as investors worry about companies' ability to repay debt will be hurt by the spreading coronavirus.Airlines are among the first U.S. companies t
Credit Market Endures Worst Day in a Decade on Virus-Fueled Rout
05:20pm, Friday, 06'th Mar 2020
U.S. credit markets are suffering their worst day in a decade as fears intensify that the spreading coronavirus will hurt corporate income and some companies’ ability to repay debt.
Alkermes Plc (NASDAQ:ALKS) Shares Sold by Korea Investment CORP
02:11pm, Friday, 06'th Mar 2020
Korea Investment CORP lowered its position in shares of Alkermes Plc (NASDAQ:ALKS) by 77.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
BRIEF-Alkermes Says Phase 3 Study Of Schizophrenia Drug Published In Medical Journal
12:38pm, Wednesday, 04'th Mar 2020
Alkermes Plc:
Fmr LLC Decreases Stock Holdings in Alkermes Plc (NASDAQ:ALKS)
12:36pm, Wednesday, 04'th Mar 2020
Fmr LLC decreased its holdings in Alkermes Plc (NASDAQ:ALKS) by 44.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,803,700 shares of the
Alkermes' schyzophrenia candidate Phase 3 results featured in publication ALKS
12:10pm, Wednesday, 04'th Mar 2020
Alkermes' schyzophrenia candidate Phase 3 results featured in publication ALKS
